Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000927:Anticonvulsants / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002531:Cerebellum / Q000187:drug effects; D004347:Drug Interactions; D004828:Epilepsies, Partial / Q000188:drug therapy; D004832:Epilepsy, Absence / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000097:blood / Q000494:pharmacology; D011247:Pregnancy; D012640:Seizures / Q000188:drug therapy
D000927:Anticonvulsants; D010672:Phenytoin; D010634:Phenobarbital